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Recent reports have suggested that WNT signaling is an important regulator for adipogenesis or insulin secretion
and might be involved in the pathogenesis of type 2 diabetes. To investigate possible roles of the WNT genes in
conferring susceptibility to type 2 diabetes, we examined the association of the genes that encode members of the
WNT family with type 2 diabetes in the Japanese population. First, 40 single-nucleotide polymorphism (SNP) loci
within 11 WNT genes were analyzed in 188 subjects with type 2 diabetes (case-1) and 564 controls (control-1).
Among them, six SNP loci exhibited a signiﬁcant difference ( ) in the allele and/or genotype distributionsP ! .05
between case and control subjects. These SNP loci were further analyzed in another set of case (case-2; )np 733
and control (control-2; ) subjects to conﬁrm their statistical signiﬁcance. As a result, one SNP locus in thenp 375
WNT5B gene was strongly associated with type 2 diabetes ( ; ; odds ; 95%2x p 15.6 Pp .00008 ratiop 1.74
conﬁdence interval 1.32–2.29). Expression of the WNT5B gene was detectable in several tissues, including adipose,
pancreas, and liver. Subsequent in vitro experiments identiﬁed the fact that expression of the Wnt5b gene was
increased at an early phase of adipocyte differentiation in mouse 3T3-L1 cells. Furthermore, overexpression of the
Wnt5b gene in preadipocytes resulted in the promotion of adipogenesis and the enhancement of adipocytokine-
gene expression. These results indicate that the WNT5B gene may contribute to conferring susceptibility to type
2 diabetes and may be involved in the pathogenesis of this disease through the regulation of adipocyte function.
Introduction
Type 2 diabetes (MIM 125853) is one of the most com-
mon diseases of middle age, and its prevalence continues
to increase steadily in many countries, including Japan.
The pathogenesis of type 2 diabetes is characterized by
the reduction of insulin secretion combined with pe-
ripheral insulin resistance (Kahn 1998), but the detailed
mechanism is still not well known.
To date, several genes have been reported as can-
didates for conferring susceptibility to type 2 diabetes,
including peroxisome proliferator-activated receptor g
(PPARG [MIM 601487]) (Altshuler et al. 2000), calpain-
10 (CAPN10 [MIM 605286]) (Horikawa et al. 2000),
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and adiponectin (APM1 [MIM 605441]) (Hara et al.
2002), although these genes can account for the con-
dition in only a small percentage of all diabetic patients;
most of the susceptibility genes for type 2 diabetes re-
main to be identiﬁed.
The WNT genes have been reported to play a pivotal
role in embryonic development and oncogenesis. Re-
cently, one isoform of theWNT family has been reported
to play an important role in adipogenesis (Ross et al.
2000; Bennett et al. 2002), and low-density lipoprotein
receptor–related protein 5 (LRP5 [MIM603506]),which
is known as a mediator forWNT signaling, has also been
shown to be involved in glucose-induced insulin secretion
(Fujino et al. 2003). Therefore, genes related to theWNT-
signaling pathway could be considered as candidate genes
for conferring susceptibility to type 2 diabetes. However,
to our knowledge, no association studies that focus on
the WNT genes have yet been reported.
In the present study, we demonstrate the results of a
case-control association study for the WNT genes in
Japanese subjects, and we provide evidence that the
Table 1
Association of the WNT Genes with Type 2 Diabetes and SNP Locations
Gene and JSNP IDa Modelb 2x Pc Chromosome
SNP Location
(Major Allele/Minor Allele)
WNT2:
IMS-JST000659 R 3.1 .078 7 Intron 24921 (C/T)
IMS-JST007915 R 3.7 .054 7 Intron 3340 (A/C)
IMS-JST011331 R 3.9 .049 7 Intron 35839 (T/C)
IMS-JST035778 R 3.2 .073 7 Intron 311329 (T/A)
IMS-JST035780 R 2.4 .120 7 Intron 36954 (A/C)
IMS-JST057756 D 2.2 .140 7 Intron 317103 (T/C)
IMS-JST111067 R 7.8 .0051 7 3′-ﬂank1629 (T/C)
IMS-JST160646 R .1 .71 7 3′-ﬂank2696 (T/C)
WNT2B:
IMS-JST068883 Allele 1.9 .31 1 Exon 6870 (C/T)
IMS-JST147806 Allele 1.1 .29 1 Intron 213176 (C/A)
IMS-JST082135 Allele 1.6 .20 1 Intron 5425 (A/G)
IMS-JST147811 D 1.7 .18 1 Intron 223287 (C/T)
IMS-JST147812 R 2.4 .12 1 Exon 6224 (G/A)
WNT3:
IMS-JST169568 Allele .9 .34 17 Intron 22715 (C/A)
WNT3A:
IMS-JST153590 R .4 .52 1 Exon 4665 (C/T)
WNT4:
IMS-JST015559 D .9 .32 1 Intron 21784 (C/T)
IMS-JST015560 D .3 .59 1 Intron 22108 (A/G)
IMS-JST015561 D .3 .56 1 Intron 22134 (G/C)
IMS-JST015562 Allele .5 .45 1 Intron 22469 (G/A)
IMS-JST119480 D .5 .45 1 Intron 4388 (C/T)
WNT5A:
IMS-JST086337 D 3.9 .049 3 Exon 42328 (G/A)
IMS-JST128940 D .7 .40 3 Intron 31875 (T/C)
IMS-JST128941 R 4.9 .026 3 Intron 31798 (C/T)
WNT5B:
IMS-JST024407 R 1.6 .20 12 Intron 41453 (T/G)
IMS-JST024409 R 5.0 .025 12 Intron 46763 (C/T)
IMS-JST024410 Allele .5 .47 12 Intron 47770 (C/T)
IMS-JST024411 D 1.4 .24 12 Intron 47976 (T/C)
IMS-JST012095 R .4 .53 12 Intron 5905 (G/A)
IMS-JST012098 2# 3 3.1 .22 12 Intron 54083 (G/T)
IMS-JST012099 R 1.2 .27 12 Intron 54148 (A/G)
IMS-JST024404 R 8.5 .0036 12 Intron 4438 (C/G)
IMS-JST012100 R 1.7 .19 12 Intron 54214 (T/C)
IMS-JST161961 Allele .6 .41 12 Intron 111798 (C/T)
IMS-JST168889 D 1.3 .25 12 Exon 1234 (G/A)
WNT9A:
IMS-JST153589 D 1.7 .19 1 Exon 258 (G/A)
WNT10B:
IMS-JST092651 R .7 .38 12 Exon 5348 (G/A)
IMS-JST138743 Allele 1.4 .23 12 3′-ﬂank244 (G/A)
WNT11:
IMS-JST091808 R .2 .64 11 Exon 389 (G/A)
WNT16:
IMS-JST159943 R 1.2 .26 7 Intron 35525 (A/G)
IMS-JST159946 D .4 .51 7 Intron 32747 (T/C)
NOTE.—In this study, 188 cases and 564 controls were examined.
a JSNP IDs selected from the IMS-JST Web site.
b D p dominant model; R p recessive model; Allele p allele frequency; p genotype2# 3
distribution ( ).2# 3
c The smallest P value among the four models is presented.
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Figure 1 LD mapping around the WNT5B gene. LD coefﬁcients (D′ and D) between every two SNPs around the SNP in intron 4 (438,
C/G) were calculated. Minor allele frequencies of all SNPs used in this analysis are 110%. An asterisk (*) highlights the SNP in intron 4 (438,
C/G).
WNT5B gene (MIM 606361) is a good candidate for
conferring susceptibility to type 2 diabetes.
Methods
DNA Preparation and SNP Genotyping
DNA samples were obtained from the peripheral blood
of patients with type 2 diabetes who came regularly to
the outpatient clinic of Shiga University of Medical Sci-
ence, TokyoWomen’sMedical University, JuntendoUni-
versity, Kawasaki Medical School, or Chibanishi Medi-
cal Hospital. The diagnosis of diabetes was determined
according to the criteria of the World Health Organiza-
tion. Type 2 diabetes was clinically deﬁned as “gradual,
adult onset of the disease.” The subjects who were posi-
tive for anti-glutamic acid decarboxylase antibody and
the patients with mitochondrial disease (mitochondrial
myopathy, encephalopathy, lactic acidosis, and strokelike
episodes [MELAS {MIM 540000}]) and maturity-onset
diabetes of the young (MODY [MIM 606391]) were ex-
cluded. Control subjects consisted of members of the
general population (control-1; ) and another setnp 564
of control subjects (control-2; ) who were re-np 375
cruited through several medical institutes in Japan. DNA
extraction was performed using a standard phenolchloro-
form procedure. Written informed consent was obtained
from each patient, and the protocol was approved by the
ethics committees of the Institute of Physical and Chemi-
cal Research and by those of each institute involved in
the study.
SNP Genotyping
The SNPs for genotyping were selected from the IMS-
JST (Institute ofMedical Science–Japan Science andTech-
nology Agency) Japanese SNP database (Hirakawa et al.
2002). First, each SNP locus within the WNT genes was
genotyped by the invader assay, as described elsewhere
(Ohnishi et al. 2001), for patients with type 2 diabetes
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Table 2
Genotype and Allele Frequencies of the SNPs in WNT5B
POPULATION
ANALYSIS OF INTRON 4438 (C/G)
No. (%) of Subjects
No. (%) of
Chromosomes HWE Testa
CC CG GG C G x2 P
Case-1 ( )np 188 89 (47.3) 75 (40) 24 (12.7) 253 (67.3) 123 (32.7) 1.6 .20
Control-1 ( )np 562 199 (35.4) 280 (50.0) 83 (14.6) 678 (60.3) 446 (39.7) .9 .32
Case-2 ( )np 733 304 (41.4) 331 (45.1) 98 (13.5) 939 (64.1) 527 (35.9) .3 .60
Control-2 ( )np 345 100 (29.0) 192 (55.6) 53 (15.4) 392 (56.8) 298 (43.2) 6.2 .013
ANALYSIS OF INTRON 46763 (C/T)
No. (%) of Subjects
No. (%) of
Chromosomes HWE Testa
CC CT TT C T 2x P
Case-1 ( )np 188 103 (54.8) 69 (36.7) 16 (8.5) 275 (73.1) 101 (26.9) .8 .36
Control-1 ( )np 558 253 (45.3) 253 (45.3) 52 (9.4) 759 (68.0) 357 (32.0) .9 .32
Case-2 ( )np 696 344 (50.0) 282 (40.5) 70 (9.5) 970 (69.7) 422 (30.3) 1.2 .28
Control-2 ( )np 366 147 (40.1) 183 (50.0) 36 (9.9) 477 (65.2) 255 (34.8) 3.8 .052
a Hardy-Weinberg equilibrium test.
Table 3
Association of the SNPS in WNT5B with Type 2 Diabetes
POPULATION
ANALYSIS OF INTRON 4438 (C/G)
Model 2x P OR 95% CI
Case-1 versus control-1 CC vs. CGGG 8.5 .0036 1.64 1.17–2.29
Case-2 versus control-2 CC vs. CGGG 15.6 .00008 1.74 1.32–2.29
ANALYSIS OF INTRON 4438 (C/G)
Model 2x P OR 95% CI
Case-1 versus control-1 CC vs. CTTT 5.0 .025 1.46 1.05–2.04
Case-2 versus control-2 CC vs. CTTT 8.3 .004 1.46 1.13–1.88
(case-1; ; male:female ratio 101:87; meanSDnp 188
age [in years] ; duration [in years] of dia-60.5 11.4
betes ; HbA1c [%] ; fasting plasma17.5 9.4 7.5 1.32
glucose [FPG] [mg/dl] ; meanSD BMI150.5 46.2
[kg/m2] ) and in the general population (con-23.5 3.4
trol-1: ). After evaluation of the statistical datanp 564
by use of four models (genotype distribution [ ],2# 3
allele frequency, dominant model, and recessive model),
the SNPs that showed signiﬁcant ( ) differencesP ! .05
were further examined in another set of diabetic subjects
(case-2; ; male:female ratio 437:296;meanSDnp 733
age [in years] ; meanSD duration [in years]60.7 11.0
of diabetes ; meanSD HbA1c [%]12.8 9.9 7.2
; meanSD FPG [mg/dl] ; meanSD1.2 159.5 42.5
BMI [kg/m2] ) and control subjects (control-23.2 3.4
2; ).np 375
SNP Discovery in the WNT5B Gene
On the basis of GenBank information about DNA se-
quence in the genomic region that contains the WNT5B
gene (GenBank accession number AC005182), we de-
signed PCR primers to amplify appropriate fragments
of genomic DNA. PCR and DNA sequencing were per-
formed as described elsewhere (Saito et al. 2001), by
study of 48 diabetic subjects.
Cell Culture and Real-Time Quantitative RT-PCR
Amouse 3T3-L1 cell line was obtained from theHealth
Science Research Resources Bank. Cells were grown to
conﬂuence and were induced to differentiate into adi-
pocytes, according to methods described elsewhere
(Kishida et al. 2001). Total RNA was extracted from
mouse 3T3-L1 cells with Trizol reagent (Invitrogen) at
different stages of adipocyte differentiation, and reverse
transcription was performed using an oligo-dT primer.
Expression of the endogenous Wnt5b gene during adi-
pogenesis and expression of the mouse PPAR-g (Pparg),
mouse C/EBP-a (Cebpa), mouse adiponectin (apM1),
and mouse leptin (Lep) genes in Wnt5b-overexpressing
3T3-L1 cells were examined at the indicated days, after
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Figure 2 Polymorphisms identiﬁed in the WNT5B gene. The number sign (#) indicates the SNP in intron 4 (438, C/G) that showed
strong association. An asterisk (*) indicates SNPs selected from the IMS-JST Japanese SNP database.
Table 4
Genotype Frequencies of SNPs in the WNT5B Gene
POSITION (MAJOR/MINOR) POPULATION
NO. (%) OF SUBJECTS
Major Allele/
Major Allele
Major Allele/
Minor Allele
Minor Allele/
Minor Allele Total
SNP 33 Case 232 (33) 327 (47) 139 (20) 698
Intron 16974 (C/T) Control 102 (28) 200 (55) 64 (17) 366
SNP 51 Case 342 (49) 298 (42) 65 (9) 705
Intron 21079 (C/G) Control 149 (41) 183 (50) 34 (9) 366
SNP 55 Case 341 (49) 297 (42) 63 (9) 701
Intron 21636 (C/G) Control 142 (39) 183 (50) 38 (11) 363
SNP 57 Case 284 (40) 318 (45) 102 (15) 704
Intron 31016 (C/T) Control 95 (28) 182 (54) 61 (18) 338
SNP 58 Case 304 (41) 331 (45) 98 (14) 733
Intron 4438 (C/G) Control 100 (29) 192 (56) 53 (15) 345
SNP 67 Case 291 (41) 313 (45) 99 (14) 703
Intron 45776 (G/C) Control 106 (29) 194 (53) 66 (18) 366
SNP 71 Case 344 (50) 282 (41) 70 (9) 696
Intron 46763 (C/T) Control 147 (40) 183 (50) 36 (10) 366
SNP 83 Case 587 (83) 114 (16) 4 (1) 705
Intron 54244 (A/C) Control 319 (88) 41 (11) 3 (1) 363
induction of differentiation by real-time quantitativeRT-
PCR (Mx3000P Multiplex Quantitative PCR system
[Stratagene]) with SYBR green detection. Results were
normalized with mouse 36B4 (Arbp). Primers for the
genes studied were as follows. For Wnt5b, sense 5′-CCA
GTG CAG AGA CCG GAG ATG-3′, antisense 5′-GTT
GTC CAC GGT GCT GCA GTT C-3′; for Arbp, sense
5′-CAA CGG CAG CAT TTA TAA CCC-3′, antisense
5′-CCC ATT GAT GAT GGA GTG TGG-3′; for Pparg,
sense 5′-TTT GAA AGA AGC GGT GAA CCA C-3′,
antisense 5′-ACC ATT GGG TCA GCT CTT GTG -3′;
for Cebpa, sense 5′-AAA GCC AAG AAG TCG GTG
GAC-3′, antisense 5′-GGT CAT TGT CAC TGG TCA
ACT CC-3′; for apM1, sense 5′-GGG TGA GAC AGG
AGA TGT TGG AAT G-3′, antisense 5′-GCC AGT AAA
TGT AGA GTC GTT GAC G-3′; for Lep, sense 5′-TCC
AGA AAG TCC AGG ATG ACA CCA A-3′, antisense
5′-TCA GCA TTC AGG GCT AAC ATC CAA C-3′. The
ampliﬁcations were each performed in a 25-ml reaction
volume that contained 1# EX Taq Buffer, 200 nM
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Table 5
Analysis of SNPs in the WNT5B Gene with Type 2 Diabetes
POSITION
x2 FOR P FOR
a2# 3 Allele
Major/Major
versus Others
Minor/Minor
versus Others a2# 3 Allele
Major/Major
versus Others
Minor/Minor
versus Others
Intron 16974 5.9 .4 3.2 .92 .053 .516 .073 .34
Intron 21079 6.4 3.4 5.9 .001 .041 .063 .015 .97
Intron 21636 8.8 6.7 8.8 .61 .013 .0099 .0031 .43
Intron 31016 14.8 11.9 14.8 2.19 .0006 .0006 .0001 .14
Intron 4438 15.8 10.4 15.6 .77 .0004 .0013 .00008 .38
Intron 45776 16.1 13.6 15.9 2.88 .0003 .0002 .00007 .09
Intron 46763 9.4 4.5 8.3 .01 .0092 .034 .004 .91
Intron 54244 4.8 3.1 4.0 .25 .092 .077 .046 .62
a Genotype distribution ( ).2# 3
Table 6
Analysis of SNPs in the WNT5B Gene with Type 2 Diabetes
POSITION
OR (95% CI) OF
Allele
Major/Major
versus Others
Minor/Minor
versus Others
Intron 16974 1.06 (.89–1.27) 1.29 (.98–1.70) .85 (.61–1.18)
Intron 21079 1.20 (.99–1.45) 1.37 (1.06–1.77) 1.01 (.65–1.56)
Intron 21636 1.28 (1.06–1.55) 1.47 (1.14–1.91) 1.18 (.77–1.81)
Intron 31016 1.39 (1.15–1.67) 1.73 (1.31–2.29) 1.30 (.92–1.84)
Intron 4438 1.35 (1.13–1.63) 1.74 (1.32–2.29) 1.18 (.82–1.69)
Intron 45776 1.41 (1.17–1.69) 1.73 (1.32–2.27) 1.34 (.95–1.89)
Intron 46763 1.23 (1.01–1.48) 1.46 (1.13–1.88) .98 (.64–1.49)
Intron 54244 .73 (.52–1.04) .69 (.47–1.00) 1.46 (.33–6.56)
dNTP, 1/20,000 SYBR Green, 800 nM gene-speciﬁc
primer, 0.05 U/ml EX Taq DNA polymerase, 2.75 ng/
ml TaqStart antibody, and 5 ng of template DNA. The
thermal proﬁle was 50C for 2 min, at 95C for 10 min,
followed by 40 cycles at 95C for 30 s and at 60C for
60 s.
Construction of Adenovirus Vector and Viral Infection
An adenovirus vector encoding the mouseWnt5b gene
was prepared using the Adenovirus Expression Vector Kit
(TaKaRa). Forty-eight hours before the induction of dif-
ferentiation, 3T3-L1 cells were transduced with a mul-
tiplicity of infection of 50 plaque-forming units/cell for
6 h, and samples were obtained at the indicated days
after induction of differentiation.
Oil Red O Staining
At the indicated number of days after induction of
differentiation, the cells were washed twice with PBS and
then were ﬁxed for 2 h with 3.7% formaldehyde. Fixed
cells were incubated with oil red O for 15 min at room
temperature. After the cells were washed once with wa-
ter, the stained lipid droplets in the cells were visualized
by light microscopy. For quantiﬁcation, the dye was ex-
tracted with isopropyl alcohol, and the absorbance was
measured at 540 nm.
Statistical Analysis
The statistical analysis used in the association study to
calculate the Hardy-Weinberg equilibrium (Nielsen et al.
1998), and the linkage disequilibrium (LD) coefﬁcients
(D′ and D) (Devlin and Risch 1995) were as described
elsewhere. The analysis of haplotype structure was per-
formed by estimation of haplotype phasing by use of the
EM algorithm (Excofﬁer and Slatkin 1995) and by con-
struction of haplotype blocks, as described elsewhere
(Gabriel et al. 2002; Tanaka et al. 2003). To analyze
interaction between SNPs, logistic regression analysis was
performed. The probability (Pc) of an individual being
a case subject rather than a control subject is assumed
to be affected by a set of SNPs, according to the logistic
model; for example, logit for a(P)p a  a x  a x0 1 1 2 2
single SNP. Here, we use a coding scheme ,x p 1,0,11
and for genotypes 1/1, 1/2, andx p 0.5,0.5, 0.52
2/2, respectively, for representing an additive effect by
and a dominance/recessive effect by (Cordell andx x1 2
Clayton 2002). The weights are estimated by the maxi-
mum-likelihood method and are tested by comparison
with the null hypothesis logit (constant). For(P)p ac 0
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Figure 3 A, Analysis of haplotype structure and estimated haplotype frequencies within the WNT5B gene. 56 p intron 3439; 57 p
intron 31016; 58p intron 4438; 67p intron 45776; 71p intron 46763. a, Haplotype 1/others: ; ; OR 1.24, 95%2x p 4.41 Pp .036
CI 1.01–1.52. b, Haplotype 2/others: ; , OR .77, 95% CI .62–.96. B, Plots of LD coefﬁcients ( ) between the SNP at intron2x p 5.59 Pp .018 D
4438 and other SNPs within the WNT5B gene.
multiple SNPs, interaction effects are also added, in ad-
dition to the main effects of additional SNPs, and are
tested stepwise, to determine whether their effects are
signiﬁcant. The tests were performed using R. To eval-
uate population structures, Wright’s F statistics were cal-
culated for 66 randomly selected SNPs. A single statistic
(FST) between each group was calculated as described
elsewhere (Weir 1996). To analyze the results of the oil
red O staining, the statistical signiﬁcance of the differ-
ence between the two groups was analyzed using the
unpaired t test. P values !.05 were considered signiﬁcant.
Results
Association Study
A total of 45 SNPs within 11 WNT genes were found
in the JSNP database. Among them, 40 SNP loci within
11 WNT genes were successfully genotyped with the in-
vader assay. As shown in table 1, six SNP loci (two in
WNT2, two in WNT5A, and two in WNT5B) showed
a signiﬁcant ( ) association with type 2 diabetes,P ! .05
and these SNP loci were further analyzed in another set
of case ( ) and control ( ) subjects. Thenp 733 np 375
results indicated that only two SNP loci in the WNT5B
gene at chromosome 12p13.3 were associated with type
2 diabetes (intron 4438, C/G, CC vs. CGGG:
, , OR 1.74, 95% CI 1.32–2.29;2x p 15.6 Pp .00008
intron 46763, C/T, CC vs. CTTT: ,2x p 8.3 Pp
, OR 1.46, 95% CI 1.13–1.88) (tables 2 and 3)..004
To exclude the possibility that this result instead re-
ﬂected the association of other genes located near the
WNT5B gene with type 2 diabetes, we performed LD
mapping around this locus, using 34 SNPs with allele
frequencies of 10.1. The result indicated that the LD in
this region extended to∼20 kb upstream and 10 kb down-
stream of this SNP site (ﬁg. 1). Hence, the crucial region
for susceptibility to type 2 diabetes seemed to exist
within this 30-kb LD block, which contained only the
WNT5B gene. Therefore, we concluded that theWNT5B
gene itself could explain the association of this locuswith
type 2 diabetes.
Next, we sought genetic polymorphisms in an entire
region of the WNT5B gene. We identiﬁed 76 additional
SNPs, for a total of 87 SNPs in this gene (ﬁg. 2). We
could not identify any variations within the coding re-
gion of the WNT5B gene. Among these 87 SNP loci, 45
SNP loci were successfully genotyped and were analyzed
in the second set of case (case-2) and control (control-2)
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Figure 4 Expression pattern of the Wnt5b gene in 3T3-L1 cells during differentiation. Quantitative real-time PCR was used to evaluate
the amount of Wnt5b mRNA. Total RNA was extracted from 3T3-L1 cells at 0, 1, 2, 3, 4, 5, 6, 7, and 10 d after induction of differentiation.
subjects. The result indicated that several of them were
signiﬁcantly associated with type 2 diabetes (tables 4–
6); the association of SNPs at intron 3 and intron 4 with
type 2 diabetes was especially strong (intron 31016:
, , OR 1.73, 95% CI 1.31–2.29;2x p 14.8 Pp .0001
intron 4438: , , OR 1.74, 95%2x p 15.6 Pp .00008
CI 1.32–2.29; intron 45776: , ,2x p 15.9 Pp .00007
OR 1.73, 95% CI 1.32–2.27).
We then examined haplotype structure using the EM
algorithm, which indicated that ﬁve SNPs with the allelic
frequency of 10.15 in theWNT5B gene, including intron
4438 C/G, constituted one haplotype block and that
ﬁve common haplotypes could cover 190% of the popu-
lation (ﬁg. 3A). Subsequent association studies for each
haplotype with type 2 diabetes identiﬁed a signiﬁcant as-
sociation of haplotypes 1 and 2 with type 2 diabetes.
However, the associations of these haplotypes were not
stronger than those found at the single locus.
We further evaluated interactions among the SNPs used
in this study by logistic regression analysis, as described
in the “Methods” section, and we identiﬁed signiﬁcant
interaction between the SNP at intron 4438 of the
WNT5B gene and the SNP at 3′-ﬂanking1629 of the
WNT2 gene (recessive for the WNT5B SNP, plus ad-
ditive for the WNT2 SNP with interaction; ,Pp .007
combined empirical ; OR 2.22; 95% CIPp .000035
1.58–3.11). We could not identify any signiﬁcant inter-
action between other combinations of the WNT genes.
Expression of Wnt5b during Adipogenesis
To learn the possible involvement of theWNT5B gene
in the pathogenesis of type 2 diabetes, we ﬁrst investi-
gated the expression pattern of the mouse Wnt5b gene
during adipogenesis, by quantitative real-time PCR. As
shown in ﬁgure 4, expression of the Wnt5b gene was
most abundant at 2 d after induction of differentiation,
followed by a rapid decrease in response as a result of
further cell differentiation into adipocytes.
Effect of Overexpression of the Mouse Wnt5b Gene
on Adipogenesis and Adipocyte Gene Expression
We next examined the effect of overexpression of the
mouse Wnt5b gene on adipocyte differentiation. 3T3-
L1 preadipocytes were infected with adenovirus vectors
encoding mouse Wnt5b or lacZ 48 h before induction
of differentiation, and cells then were induced to differ-
entiate into adipocytes, as described in the “Methods”
section. As shown in ﬁgure 5A and 5B, the cells over-
expressing Wnt5b signiﬁcantly accelerated differentiation
of 3T3-L1 cells compared with control cells (the content
of lipid droplets was 1.6-fold, 1.9-fold, and 1.7-fold at
4, 7, and 10 d, respectively; vs. lacZ).P ! .05
Expression of the Cebpa and Pparg genes, which are
thought to play a key role in the adipogenesis process,
was also elevated in the Wnt5b-overexpressing cells (ﬁg.
6A and 6B). We further examined the expression of sev-
eral adipocytokine genes in the same cells and identiﬁed
that the expression of apM1 and Lep was signiﬁcantly
increased in Wnt5b-overexpressing cells compared with
control cells (apM1 is expressed 2.0-fold and 1.5-fold,
and Lep is expressed 1.6-fold and 1.7-fold, at day 3 and
day 7, respectively [ﬁg. 6C and 6D]), whereas the ex-
pression of Il-6 and Rstn was unchanged between these
two cell lines (data not shown).
Discussion
In this study, we examined the association of the WNT
genes with type 2 diabetes, and we identiﬁed theWNT5B
gene at chromosome 12p13.3 as a new candidate for
conferring susceptibility to type 2 diabetes. Recent cu-
mulative evidence suggested that some members of the
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Figure 5 Effects of Wnt5b gene overexpression in 3T3-L1 cells on adipogenesis. An adenovirus vector encoding the Wnt5b gene was
infected into 3T3-L1 cells 48 h before induction of differentiation at a multiplicity of infection of 50. A, Lipid droplets stained with oil red O
at 5 d after induction of differentiation. B, Quantitative analysis of oil red O staining. Values are meanSE of ﬁve independent experiments.
An asterisk (*) indicates versus control cells (LacZ).P ! .05
WNT family had remarkable functions in relation to the
pathogenesis of type 2 diabetes. To date, the WNT fami-
ly consists of 19 genes, including the WNT5B gene (de-
tails can be viewed on the Wnt Web site). Most WNT
proteins are considered to be secreted from cells and to
act through cell-surface receptors, namely Frizzled re-
ceptors and their coreceptors LRP5 and LRP6 (MIM
603507). The WNT1 gene (MIM 164820) has been re-
ported to inhibit adipogenesis through the b-catenin
pathway (Ross et al. 2000), and the WNT10B (MIM
601906) gene has also been shown to play an important
role in an early stage of adipogenesis (Bennett et al.
2002). In addition, it has been reported that LRP5 plays
some role in glucose-induced insulin secretion in the pan-
creatic islets and in cholesterol metabolism in the liver
(Fujino et al. 2003). On the basis of these observations,
the WNT genes seem to be worthy candidates for con-
ferring susceptibility to type 2 diabetes, but, until now,
the association of these genes with type 2 diabetes had
not, to our knowledge, been examined.
In this study, we identiﬁed a signiﬁcant association
of SNP loci within the WNT5B gene with type 2 dia-
betes. Because we examined the association between 40
SNP loci in 11 WNT genes and type 2 diabetes, by use
of four models for each locus, type 1 error due to mul-
tiple testing should be included. To eliminate the pos-
sibility of type 1 error, we adopted Bonferroni’s method
to our overall analytical process, according to the fol-
lowing calculation: overall P values (P test-1# P test-
2) were multiplied by the number of tests (40# 4
). The corrected P value obtained for a particular6# 4
SNP within the WNT5B gene was .00005 (.0036#
); thus, the association of this locus.00008# 46# 4
with type 2 diabetes was thought to be statistically
signiﬁcant.
We further compared population structures among
the case and control groups to conﬁrm that our repli-
cation samples were appropriately collected for the study.
The average values of between each group suggestedFST
that there was no population stratiﬁcation within each
group (average , 0.0032, 0.0089, andF p 0.0018ST
0.0014, calculated by comparison between case-1 and
case-2, control-1 and control-2, case-1 and control-1,
and case-2 and control-2, respectively).
Subsequent LD mapping revealed that the LD block
of this locus contained only the WNT5B gene (ﬁg. 1).
Therefore, theWNT5B gene itself should be a candidate
for conferring susceptibility to type 2 diabetes. Because
the gene encoding APM1 type 2 receptor (ADIPOR2
[MIM 607946]), which was recently identiﬁed and con-
sidered to be a candidate gene for type 2 diabetes, was
located next to the WNT5B gene, we also analyzed
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Figure 6 Effects of Wnt5b gene overexpression in 3T3-L1 cells on adipocyte gene expression: the expression of Pparg (A), Cebpa (B),
apM1 (C), and Lep (D) in Wnt5b overexpressing 3T3-L1 cells at 3 and 7 d after induction of differentiation. The results obtained from four
independent experiments are presented. An asterisk (*) indicates that . A double asterisk (**) indicates versus control cells (LacZ).P ! .05 P ! .01
seven SNPs in ADIPOR2, but we could not identify any
association between them and type 2 diabetes ( ;P 1 .05
data not shown).
On the basis of previous reports, expression of the
WNT5B gene appears to be moderately detectable in
adult prostate and fetal brain and weakly detectable in
adult liver and kidney (Saitoh et al. 2001). It was also
reported that the Wnt5b gene is involved in the differ-
entiation and proliferation of several types of cells, such
as chondrocytes (Yang et al. 2003), and that expression
of the Wnt5b gene is transiently increased during myo-
genesis (Jamali et al. 2001). However the involvement
of this gene in the pathogenesis of type 2 diabetes has
not emerged thus far. To our knowledge, the present
study is the ﬁrst to demonstrate clear expression of the
Wnt5b gene in 3T3-L1 adipocytes. It is interesting that
expression of the Wnt5b gene was transiently in-
creased at an early phase of adipogenesis, which sug-
gests some role for this gene in the regulation of adi-
pocyte differentiation.
In a previous report, other members of theWNT fami-
ly, WNT1 and WNT10B, were shown to be capable of
inhibiting adipocyte differentiation (Ross et al. 2000).
We therefore examined a possible role of the Wnt5b
gene in adipogenesis, using 3T3-L1 cells overexpressing
theWnt5b gene. The present study clearly demonstrates
that overexpression of the Wnt5b gene in preadipocytes
results in the promotion of adipocyte differentiation,
when compared with the control cells. The expression
of Pparg and Cebpa, which are essential transcription
factors for adipogenesis, was also increased in Wnt5b-
overexpressing 3T3-L1 cells. Therefore, it appears that
the Wnt5b gene has an opposite effect on adipogenesis,
when compared with WNT1 or WNT10B. We also
identiﬁed that the expression of several anti-apoptotic
genes, such as insulinlike growth factor-1 (Igf-1) and
WNT1-inducible secreting protein-1 (Wisp1), was de-
creased in Wnt5b-overexpressing 3T3-L1 cells (Igf-1,
36% and 44%; Wisp1, 30% and 44% at day 0 and
day 2, respectively; authors’ unpublished data). Because
these genes are thought to be a downstream target of
the WNT-1/b-catenin–signaling pathway—which has
an anti-apoptotic action by activation of Akt kinase (Su
et al. 2002) and is reported to be upregulated by over-
expression of the WNT1 gene in 3T3-L1 cells (Longo
et al. 2002)—Wnt5b has the opposite effect of WNT1,
in terms of the regulation of adipocyte function.
The mechanism by which theWNT5B gene can affect
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the susceptibility to type 2 diabetes remains uncertain.
Differentiated adipocytes have been known to act as
endocrine cells and are known to be capable of secreting
several cytokines, so-called “adipocytokines.” These cy-
tokines, which are produced and secreted by adipocytes,
were thought to be involved in systemic insulin sensi-
tivity. Therefore, we examined the expression of several
adipocytokine genes in Wnt5b-overexpressing 3T3-L1
cells and identiﬁed that the overexpression of theWnt5b
gene resulted in signiﬁcant increases in the expression
of apM1 and Lep in 3T3-L1 cells. From these obser-
vations, we hypothesized that the difference in the ex-
pression or function of the WNT5B gene among the
individuals could contribute to the susceptibility to type
2 diabetes through, at least in part, affecting adipocyte
function, including the production of adipocytokines,
although the elucidation of the precise mechanism re-
quires further study.
Finally, it should be mentioned that the OR for the
SNP associated with type 2 diabetes in this study was
not very high, even when the association of the SNP was
shown to be strong by x2 test. This discrepancy is prob-
ably explained by the fact that multiple genetic factors
are involved in susceptibility to type 2 diabetes in a com-
plex manner, and effects of individual genes in a complex
genetic and environmental background are often very
small on their own. Therefore, evaluation of interactions
among individual genes with and without main effects is
necessary for full understanding of the involvement of
genetic background for conferring susceptibility to type
2 diabetes. In the present study, we examined interaction
between the SNPs among genes encoding the WNT fam-
ily, and we identiﬁed signiﬁcant interaction between
WNT5B and WNT2 (MIM 147870). However, inter-
action with other gene families should be examined in
the future, and those kinds of studies will contribute to
further understanding of the mechanism of the genetic
susceptibility to type 2 diabetes.
In conclusion, we have identiﬁed the WNT5B gene
as a new candidate for conferring susceptibility to type
2 diabetes. Our results also suggest that the WNT5B
gene plays an important role in the regulation of adi-
pocyte function and might contribute to the pathogen-
esis of type 2 diabetes.
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